• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results

    4/28/25 5:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology
    Get the next $EVLV alert in real time by email

    — Company Regains Compliance with SEC Reporting and NASDAQ Listing Requirements —

    — Company Achieves Positive Adjusted EBITDA1 in Q4'24 —

    • Q4'24 Revenue of $29.1 million, up 41% year-over-year
    • Q4'24 Ending ARR2 of $99.4 million, up 39% year-over-year
    • Q4'24 Adjusted EBITDA of $0.4 million
    • Q4'24 Ending RPO3 of $266.7 million

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter and year ended December 31, 2024 and the filing of its 2024 Annual Report on Form 10-K with the U.S. Securities and Exchange Commission ("SEC"). The Company concurrently filed with the SEC its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, and restated financial results for the periods from the second quarter of 2022 through the second quarter of 2024. The restatements correct inaccurate accounting for certain sales transactions that led to premature or incorrectly recognized revenue. The errors resulted in premature or incorrect recognition of approximately $3.1 million of revenue on a net basis from the second quarter of 2022 through the second quarter of 2024 (considering revenue prematurely recognized but offset by amounts appropriately recognized in subsequent periods).

    "Completing this restatement—which brings the Company back into full compliance with SEC reporting and Nasdaq listing requirements—marks an important milestone in our ongoing work to rebuild stakeholder confidence," said John Kedzierski, President and Chief Executive Officer of Evolv Technology, Inc. "Looking ahead, we are focused on prioritizing disciplined execution, transparent communication, and an unwavering commitment to best-in-class compliance. With both the restatement and the FTC resolution now firmly behind us and having achieved our long-standing profitability goals six months ahead of schedule, we believe we are well-positioned as we enter our next phase of growth. We are poised to lead the transformation of the security technology landscape—making the world a safer place where people can live, work, learn, and play."

    Total revenue for the third quarter of 2024 was $27.4 million, an increase of 37% compared to $20.0 million (as restated) for the third quarter of 2023. Annual Recurring Revenue ("ARR")2 was $93.7 million at the end of third quarter of 2024, an increase of 46% compared to $64.4 million (as restated) at the end of the third quarter of 2023. Net loss for the third quarter of 2024 was $(30.4) million, or $(0.19) per basic and diluted share, compared to net income of $5.0 million (as restated), or $0.03 (as restated) per basic and diluted share, in the third quarter of 2023. Adjusted earnings (loss)1 for the third quarter of 2024 was $(6.9) million, or $(0.04) per diluted share, compared to adjusted earnings (loss)1 of $(12.4) million (as restated), or $(0.08) per diluted share, for the third quarter of 2023. Adjusted EBITDA1 for the third quarter of 2024 was $(3.0) million compared to $(11.6) million (as restated) in the third quarter of 2023. As of September 30, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $56.3 million and no debt.

    Total revenue for the nine months ended September 30, 2024 was $74.8 million, an increase of 27% compared to $59.0 million (as restated) for the nine months ended September 30, 2023. Net loss for the nine months ended September 30, 2024 was $(38.3) million, or $(0.25) per basic and diluted share, compared to $(90.9) million (as restated), or $(0.61) (as restated) per basic and diluted share, in the nine months ended September 30, 2023. Adjusted earnings (loss)1 for the nine months ended September 30, 2024 was $(30.8) million, or $(0.20) per diluted share, compared to adjusted earnings (loss)1 of $(44.2) million (as restated), or $(0.30) (as restated) per diluted share, for the nine months ended September 30, 2023. Adjusted EBITDA1 for the nine months ended September 30, 2024 was $(21.3) million compared to $(41.6) million (as restated) in the nine months ended September 30, 2023.

    Results for the Fourth Quarter of 2024

    Total revenue for the fourth quarter of 2024 was $29.1 million, an increase of 41% compared to $20.6 million (as restated) for the fourth quarter of 2023. Annual Recurring Revenue ("ARR")2 was $99.4 million at the end of fourth quarter of 2024, an increase of 39% compared to $71.3 million (as restated) at the end of the fourth quarter of 2023. Net loss for the fourth quarter of 2024 was $(15.7) million, or $(0.10) per basic and diluted share, compared to net loss of $(17.2) million (as restated), or $(0.11) per basic and diluted share, in the fourth quarter of 2023. Adjusted earnings (loss)1 for the fourth quarter of 2024 was $(4.4) million, or $(0.03) per diluted share, compared to adjusted earnings (loss)1 of $(11.8) million (as restated), or $(0.08) (as restated) per diluted share, for the fourth quarter of 2023. Adjusted EBITDA1 for the fourth quarter of 2024 was $0.4 million compared to $(10.3) million (as restated) in the fourth quarter of 2023. As of December 31, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $51.9 million and no debt. Remaining Performance Obligation3 as of December 31, 2024 was $266.7 million. The Company had approximately 6,100 units deployed as of December 31, 2024, reflecting a one time adjustment to remove approximately (100) non-revenue generating units from the Company's deployed unit count related to Evolv Edge, the Company's first generation product offering.

    Total revenue for the twelve months ended December 31, 2024 was $103.9 million, an increase of 31% compared to $79.6 million (as restated) for the twelve months ended December 31, 2023. Net loss for the twelve months ended December 31, 2024 was $(54.0) million, or $(0.34) per basic and diluted share, compared to $(108.0) million (as restated), or $(0.72) (as restated) per basic and diluted share, in the twelve months ended December 31, 2023. Adjusted earnings (loss)1 for the twelve months ended December 31, 2024 was $(35.3) million, or $(0.23) per diluted share, compared to adjusted earnings (loss)1 of $(56.0) million (as restated), or $(0.38) (as restated) per diluted share, for the twelve months ended December 31, 2023. Adjusted EBITDA1 for the twelve months ended December 31, 2024 was $(21.0) million compared to $(51.8) million (as restated) in the twelve months ended December 31, 2023.

    The following table summarizes the breakdown of recurring and non-recurring revenue4 for each period presented:

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

    2024

     

    2023

     

    % Change

     

    2024

     

    2023

     

    % Change

     

     

     

    (Restated)

     

     

     

     

     

    (Restated)

     

     

    Recurring revenue

    $

    23,678

     

    $

    17,074

     

    39

    %

     

    $

    87,419

     

    $

    50,915

     

    72

    %

    Non-recurring revenue

     

    5,422

     

     

    3,506

     

    55

    %

     

     

    16,446

     

     

    28,650

     

    (43

    )%

    Total revenue

    $

    29,100

     

    $

    20,580

     

    41

    %

     

    $

    103,865

     

    $

    79,565

     

    31

    %

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2024

     

    2023

     

    % Change

     

    2024

     

    2023

     

    % Change

     

     

     

    (Restated)

     

     

     

     

     

    (Restated)

     

     

    Recurring revenue

    $

    23,764

     

    $

    13,907

     

    71

    %

     

    $

    63,741

     

    $

    33,841

     

    88

    %

    Non-recurring revenue

     

    3,596

     

     

    6,054

     

    (41

    )%

     

     

    11,024

     

     

    25,144

     

    (56

    )%

    Total revenue

    $

    27,360

     

    $

    19,961

     

    37

    %

     

    $

    74,765

     

    $

    58,985

     

    27

    %

    The following table summarizes operating cash flows for each period presented:

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Net loss

    $

    (15,720

    )

     

    $

    (17,198

    )

     

    $

    (54,017

    )

     

    $

    (108,048

    )

    Non-cash expense

     

    6,870

     

     

     

    7,461

     

     

     

    22,504

     

     

     

    59,199

     

    Changes in operating assets and liabilities

     

    12,054

     

     

     

    6,594

     

     

     

    660

     

     

     

    39,048

     

    Net cash used in operating activities

    $

    3,204

     

     

    $

    (3,143

    )

     

    $

    (30,853

    )

     

    $

    (9,801

    )

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Net loss

    $

    (30,443

    )

     

    $

    5,046

     

     

    $

    (38,297

    )

     

    $

    (90,850

    )

    Non-cash expense

     

    26,306

     

     

     

    (16,055

    )

     

     

    15,634

     

     

     

    51,738

     

    Changes in operating assets and liabilities

     

    7,812

     

     

     

    13,106

     

     

     

    (11,394

    )

     

     

    32,454

     

    Net cash used in operating activities

    $

    3,675

     

     

    $

    2,097

     

     

    $

    (34,057

    )

     

    $

    (6,658

    )

    About Evolv Technology

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV) is designed to transform human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than two billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal's (SBJ) 2024 awards for "Best In Fan Experience Technology" and "Best In Sports Technology". Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

    1 Non-GAAP Financial Measures In this press release, the Company's adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of lease equipment, one-time employee separation costs, and one-time legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. One time legal and regulatory costs include one-time legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain one-time regulatory, litigation and legal matters, as well as fees related to the resolution of the U.S. Federal Trade Commission investigation. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense, amortization of capitalized stock-based compensation, losses from impairment of intangible assets, one-time employee separation costs, and one-time inventory charges, which management believes provides a more meaningful representation of contribution margin. Adjusted operating loss is defined as operating loss, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, losses from impairment of lease equipment and intangible assets, one-time employee separation costs, one-time inventory charges, and one-time legal and regulatory expenses, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), provision for income taxes, loss on extinguishment of debt, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of lease equipment and intangible assets, one-time employee separation costs, one-time inventory charges, and one-time legal and regulatory expenses. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, loss on extinguishment of debt, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of lease equipment and intangible assets, one-time employee separation costs, one-time inventory charges, and one-time legal and regulatory expenses. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted Gross Margin to GAAP Gross Margin and Adjusted EBITDA to Net Income (Loss), each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company's control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of derivative liabilities, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company's future financial results.

    2 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

    3 We define Remaining Performance Obligation, or RPO, as estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied or partially satisfied as of the end of the quarter.

    4 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is one-time in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, commitments, and future financial and operational results. Words such as "believe" "may," "will," "expect," "should," "could," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "project," "plan," "target," "forecast", "is/are likely to" or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: relating to our history of losses and ability to reach profitability; our reliance on reseller partners to generate a growing portion of our revenue; expectations regarding the Company's strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company's reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company's intellectual property rights and use of "open source" software; the concentration of the Company's revenues on a single solution; the Company's ability to timely design, produce and launch its solutions, the Company's ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company's securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Securities and Exchange Commission ("SEC") on April 28, 2025, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

    You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

     

    EVOLV TECHNOLOGY

    CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

    (In thousands, except share and per share data)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Revenue:

     

     

     

     

     

     

     

    Product revenue

    $

    1,675

     

     

    $

    1,848

     

     

    $

    6,464

     

     

    $

    22,768

     

    Subscription revenue

     

    17,263

     

     

     

    12,468

     

     

     

    65,046

     

     

     

    36,201

     

    Service revenue

     

    6,564

     

     

     

    4,856

     

     

     

    23,467

     

     

     

    15,606

     

    License fee and other revenue

     

    3,598

     

     

     

    1,408

     

     

     

    8,888

     

     

     

    4,990

     

    Total revenue

     

    29,100

     

     

     

    20,580

     

     

     

    103,865

     

     

     

    79,565

     

    Cost of revenue:

     

     

     

     

     

     

     

    Cost of product revenue

     

    2,166

     

     

     

    4,692

     

     

     

    10,735

     

     

     

    27,967

     

    Cost of subscription revenue

     

    8,604

     

     

     

    4,984

     

     

     

    27,846

     

     

     

    14,760

     

    Cost of service revenue

     

    1,476

     

     

     

    1,166

     

     

     

    5,399

     

     

     

    3,982

     

    Cost of license fee and other revenue

     

    113

     

     

     

    177

     

     

     

    597

     

     

     

    949

     

    Total cost of revenue

     

    12,359

     

     

     

    11,019

     

     

     

    44,577

     

     

     

    47,658

     

    Gross profit

     

    16,741

     

     

     

    9,561

     

     

     

    59,288

     

     

     

    31,907

     

    Operating expenses:

     

     

     

     

     

     

     

    Research and development

     

    5,390

     

     

     

    6,303

     

     

     

    23,446

     

     

     

    24,473

     

    Sales and marketing

     

    13,455

     

     

     

    14,344

     

     

     

    61,291

     

     

     

    54,986

     

    General and administrative

     

    16,759

     

     

     

    11,128

     

     

     

    56,634

     

     

     

    42,182

     

    Loss from impairment of property and equipment

     

    15

     

     

     

    —

     

     

     

    224

     

     

     

    322

     

    Total operating expenses

     

    35,619

     

     

     

    31,775

     

     

     

    141,595

     

     

     

    121,963

     

    Loss from operations

     

    (18,878

    )

     

     

    (22,214

    )

     

     

    (82,307

    )

     

     

    (90,056

    )

    Other income (expense), net:

     

     

     

     

     

     

     

    Interest expense

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (654

    )

    Interest income

     

    548

     

     

     

    1,630

     

     

     

    2,942

     

     

     

    6,227

     

    Other expense, net

     

    (50

    )

     

     

    (17

    )

     

     

    (83

    )

     

     

    (84

    )

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (626

    )

    Change in fair value of contingent earn-out liability

     

    1,218

     

     

     

    2,452

     

     

     

    16,310

     

     

     

    (14,901

    )

    Change in fair value of contingently issuable common stock liability

     

    311

     

     

     

    422

     

     

     

    2,529

     

     

     

    (3,138

    )

    Change in fair value of public warrant liability

     

    1,131

     

     

     

    580

     

     

     

    6,592

     

     

     

    (4,765

    )

    Total other income (expense), net

     

    3,158

     

     

     

    5,067

     

     

     

    28,290

     

     

     

    (17,941

    )

    Loss before income taxes

     

    (15,720

    )

     

     

    (17,147

    )

     

     

    (54,017

    )

     

     

    (107,997

    )

    Provision for income taxes

     

    —

     

     

     

    (51

    )

     

    $

    —

     

     

    $

    (51

    )

    Net loss

    $

    (15,720

    )

     

    $

    (17,198

    )

     

    $

    (54,017

    )

     

    $

    (108,048

    )

    Net income (loss) attributable to common stockholders – basic and diluted

    $

    (15,720

    )

     

    $

    (17,198

    )

     

    $

    (54,017

    )

     

    $

    (108,048

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    158,997,410

     

     

     

    151,087,430

     

     

     

    156,573,886

     

     

     

    149,168,105

     

    Diluted

     

    158,997,410

     

     

     

    151,087,430

     

     

     

    156,573,886

     

     

     

    149,168,105

     

    Net loss per share

     

     

     

     

     

     

     

    Basic

    $

    (0.10

    )

     

    $

    (0.11

    )

     

    $

    (0.34

    )

     

    $

    (0.72

    )

    Diluted

    $

    (0.10

    )

     

    $

    (0.11

    )

     

    $

    (0.34

    )

     

    $

    (0.72

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – basic and diluted

     

    158,997,410

     

     

     

    151,087,430

     

     

     

    156,573,886

     

     

     

    149,168,105

     

    Net loss per share - basic and diluted

    $

    (0.10

    )

     

    $

    (0.11

    )

     

    $

    (0.34

    )

     

    $

    (0.72

    )

     

     

     

     

     

     

     

     

    Net loss

    $

    (15,720

    )

     

    $

    (17,198

    )

     

    $

    (54,017

    )

     

    $

    (108,048

    )

    Other comprehensive income (loss)

     

     

     

     

     

     

     

    Cumulative translation adjustment

     

    96

     

     

     

    (44

    )

     

     

    21

     

     

     

    (43

    )

    Total other comprehensive income (loss)

     

    96

     

     

     

    (44

    )

     

     

    21

     

     

     

    (43

    )

    Total comprehensive loss

    $

    (15,624

    )

     

    $

    (17,242

    )

     

    $

    (53,996

    )

     

    $

    (108,091

    )

     

    EVOLV TECHNOLOGY

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

     

     

    December 31, 2024

     

    December 31, 2023

     

     

     

    (Restated)

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    37,015

     

     

    $

    67,162

     

    Restricted cash

     

    —

     

     

     

    275

     

    Marketable securities

     

    14,927

     

     

     

    51,289

     

    Accounts receivable, net

     

    28,392

     

     

     

    21,547

     

    Inventory

     

    16,963

     

     

     

    10,344

     

    Current portion of contract assets

     

    799

     

     

     

    1,397

     

    Current portion of commission asset

     

    5,429

     

     

     

    4,387

     

    Prepaid expenses and other current assets

     

    17,921

     

     

     

    16,957

     

    Total current assets

     

    121,446

     

     

     

    173,358

     

    Contract assets, noncurrent

     

    657

     

     

     

    964

     

    Commission asset, noncurrent

     

    7,567

     

     

     

    7,249

     

    Property and equipment, net

     

    123,661

     

     

     

    113,161

     

    Operating lease right-of-use assets

     

    13,993

     

     

     

    1,195

     

    Other assets

     

    735

     

     

     

    1,202

     

    Total assets

    $

    268,059

     

     

    $

    297,129

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    10,492

     

     

    $

    17,400

     

    Accrued expenses and other current liabilities

     

    19,508

     

     

     

    15,703

     

    Current portion of deferred revenue

     

    64,506

     

     

     

    46,808

     

    Current portion of operating lease liabilities

     

    2,203

     

     

     

    1,391

     

    Total current liabilities

     

    96,709

     

     

     

    81,302

     

    Deferred revenue, noncurrent

     

    20,266

     

     

     

    25,149

     

    Operating lease liabilities, noncurrent

     

    12,326

     

     

     

    —

     

    Contingent earn-out liability

     

    12,809

     

     

     

    29,119

     

    Contingently issuable common stock liability

     

    4,001

     

     

     

    6,530

     

    Public warrant liability

     

    4,297

     

     

     

    10,889

     

    Total liabilities

     

    150,408

     

     

     

    152,989

     

     

     

     

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2024 and December 31, 2023; no shares issued and outstanding at December 31, 2024 and December 31, 2023

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2024 and December 31, 2023; 159,602,069 and 151,310,080 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively

     

    16

     

     

     

    15

     

    Additional paid-in capital

     

    472,331

     

     

     

    444,825

     

    Accumulated other comprehensive loss

     

    (32

    )

     

     

    (53

    )

    Accumulated deficit

     

    (354,664

    )

     

     

    (300,647

    )

    Stockholders' equity

     

    117,651

     

     

     

    144,140

     

    Total liabilities and stockholders' equity

    $

    268,059

     

     

    $

    297,129

     

    EVOLV TECHNOLOGY

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

     
     

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (54,017

    )

     

    $

    (108,048

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

    Depreciation and amortization

     

    17,375

     

     

     

    9,702

     

    Write-off of inventory and change in inventory reserve

     

    2,578

     

     

     

    1,309

     

    Loss from impairment of property and equipment

     

    224

     

     

     

    322

     

    Loss from impairment of intangible asset

     

    983

     

     

     

    —

     

    Stock-based compensation

     

    24,756

     

     

     

    24,129

     

    Non-cash interest expense

     

    —

     

     

     

    22

     

    Amortization (accretion) of premium (discount) on marketable securities, net of change in accrued interest

     

    447

     

     

     

    (575

    )

    Non-cash lease expense

     

    1,420

     

     

     

    478

     

    Change in allowance for expected credit losses

     

    152

     

     

     

    382

     

    Loss on extinguishment of debt

     

    —

     

     

     

    626

     

    Change in fair value of earn-out liability

     

    (16,310

    )

     

     

    14,901

     

    Change in fair value of contingently issuable common stock

     

    (2,529

    )

     

     

    3,138

     

    Change in fair value of public warrant liability

     

    (6,592

    )

     

     

    4,765

     

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    (6,997

    )

     

     

    4,510

     

    Inventory

     

    (7,852

    )

     

     

    960

     

    Commission assets

     

    (1,360

    )

     

     

    (2,779

    )

    Contract assets

     

    905

     

     

     

    1,383

     

    Other assets

     

    467

     

     

     

    633

     

    Prepaid expenses and other current assets

     

    (964

    )

     

     

    (2,426

    )

    Accounts payable

     

    192

     

     

     

    (5,963

    )

    Deferred revenue

     

    12,815

     

     

     

    39,488

     

    Accrued expenses and other current liabilities

     

    4,534

     

     

     

    3,857

     

    Operating lease liability

     

    (1,080

    )

     

     

    (615

    )

    Net cash used in operating activities

     

    (30,853

    )

     

     

    (9,801

    )

    Cash flows from investing activities:

     

     

     

    Development of internal-use software

     

    (6,125

    )

     

     

    (3,535

    )

    Purchases of property and equipment

     

    (31,189

    )

     

     

    (69,134

    )

    Proceeds from sale of property and equipment

     

    —

     

     

     

    270

     

    Purchases of marketable securities

     

    (29,367

    )

     

     

    (89,898

    )

    Proceeds from maturities of marketable securities

     

    65,282

     

     

     

    39,184

     

    Net cash provided by (used in) investing activities

     

    (1,399

    )

     

     

    (123,113

    )

    Cash flows from financing activities:

     

     

     

    Proceeds from exercise of stock options

     

    1,809

     

     

     

    668

     

    Proceeds from long-term debt

     

    —

     

     

     

    1,876

     

    Repayment of principal on long-term debt

     

    —

     

     

     

    (31,876

    )

    Payment of debt issuance costs and prepayment penalty

     

    —

     

     

     

    (332

    )

    Net cash provided by (used in) financing activities

     

    1,809

     

     

     

    (29,664

    )

    Effect of exchange rate changes on cash and cash equivalents

     

    21

     

     

     

    (43

    )

    Net decrease in cash, cash equivalents and restricted cash

     

    (30,422

    )

     

     

    (162,621

    )

    Cash, cash equivalents and restricted cash

     

     

     

    Cash, cash equivalents and restricted cash at beginning of period

     

    67,437

     

     

     

    230,058

     

    Cash, cash equivalents and restricted cash at end of period

    $

    37,015

     

     

    $

    67,437

     

     
     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

    (In thousands, except share and per share data)

    (Unaudited

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Revenue:

     

     

     

     

     

     

     

    Product revenue

    $

    1,344

     

     

    $

    3,456

     

     

    $

    4,789

     

     

    $

    20,920

     

    Subscription revenue

     

    17,909

     

     

     

    9,858

     

     

     

    47,783

     

     

     

    23,733

     

    Service revenue

     

    6,085

     

     

     

    4,345

     

     

     

    16,903

     

     

     

    10,750

     

    License fee and other revenue

     

    2,022

     

     

     

    2,302

     

     

     

    5,290

     

     

     

    3,582

     

    Total revenue

     

    27,360

     

     

     

    19,961

     

     

     

    74,765

     

     

     

    58,985

     

    Cost of revenue:

     

     

     

     

     

     

     

    Cost of product revenue

     

    2,616

     

     

     

    3,496

     

     

     

    8,569

     

     

     

    23,275

     

    Cost of subscription revenue

     

    7,348

     

     

     

    4,157

     

     

     

    19,242

     

     

     

    9,776

     

    Cost of service revenue

     

    1,404

     

     

     

    1,219

     

     

     

    3,923

     

     

     

    2,816

     

    Cost of license fee and other revenue

     

    183

     

     

     

    198

     

     

     

    484

     

     

     

    772

     

    Total cost of revenue

     

    11,551

     

     

     

    9,070

     

     

     

    32,218

     

     

     

    36,639

     

    Gross profit

     

    15,809

     

     

     

    10,891

     

     

     

    42,547

     

     

     

    22,346

     

    Operating expenses:

     

     

     

     

     

     

     

    Research and development

     

    5,810

     

     

     

    6,386

     

     

     

    18,056

     

     

     

    18,170

     

    Sales and marketing

     

    14,966

     

     

     

    14,408

     

     

     

    47,836

     

     

     

    40,642

     

    General and administrative

     

    13,976

     

     

     

    11,261

     

     

     

    39,875

     

     

     

    31,054

     

    Loss from impairment of property and equipment

     

    209

     

     

     

    28

     

     

     

    209

     

     

     

    322

     

    Total operating expenses

     

    34,961

     

     

     

    32,083

     

     

     

    105,976

     

     

     

    90,188

     

    Loss from operations

     

    (19,152

    )

     

     

    (21,192

    )

     

     

    (63,429

    )

     

     

    (67,842

    )

    Other income (expense), net:

     

     

     

     

     

     

     

    Interest expense

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (654

    )

    Interest income

     

    628

     

     

     

    1,791

     

     

     

    2,394

     

     

     

    4,597

     

    Other income (expense), net

     

    34

     

     

     

    (64

    )

     

     

    (33

    )

     

     

    (67

    )

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (626

    )

    Change in fair value of contingent earn-out liability

     

    (8,321

    )

     

     

    14,078

     

     

     

    15,092

     

     

     

    (17,353

    )

    Change in fair value of contingently issuable common stock liability

     

    (2,056

    )

     

     

    2,277

     

     

     

    2,218

     

     

     

    (3,560

    )

    Change in fair value of public warrant liability

     

    (1,576

    )

     

     

    8,156

     

     

     

    5,461

     

     

     

    (5,345

    )

    Total other (expense) income, net

     

    (11,291

    )

     

     

    26,238

     

     

     

    25,132

     

     

     

    (23,008

    )

    Net (loss) income

    $

    (30,443

    )

     

    $

    5,046

     

     

    $

    (38,297

    )

     

    $

    (90,850

    )

    Net (loss) income attributable to common stockholders – basic and diluted

    $

    (30,443

    )

     

    $

    4,983

     

     

    $

    (38,297

    )

     

    $

    (90,850

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    157,709,229

     

     

     

    150,206,893

     

     

     

    155,760,149

     

     

     

    148,521,299

     

    Diluted

     

    157,709,229

     

     

     

    173,976,375

     

     

     

    155,760,149

     

     

     

    148,521,299

     

    Net (loss) income per share

     

     

     

     

     

     

     

    Basic

    $

    (0.19

    )

     

    $

    0.03

     

     

    $

    (0.25

    )

     

    $

    (0.61

    )

    Diluted

    $

    (0.19

    )

     

    $

    0.03

     

     

    $

    (0.25

    )

     

    $

    (0.61

    )

     

     

     

     

     

     

     

     

    Net (loss) income

    $

    (30,443

    )

     

    $

    5,046

     

     

    $

    (38,297

    )

     

    $

    (90,850

    )

    Other comprehensive (loss) income

     

     

     

     

     

     

     

    Cumulative translation adjustment

     

    (86

    )

     

     

    34

     

     

     

    (75

    )

     

     

    1

     

    Total other comprehensive (loss) income

     

    (86

    )

     

     

    34

     

     

     

    (75

    )

     

     

    1

     

    Total comprehensive (loss) income

    $

    (30,529

    )

     

    $

    5,080

     

     

    $

    (38,372

    )

     

    $

    (90,849

    )

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    September 30, 2024

     

    December 31, 2023

     

     

     

    (Restated)

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    46,033

     

     

    $

    67,162

     

    Restricted cash

     

    275

     

     

     

    275

     

    Marketable securities

     

    9,960

     

     

     

    51,289

     

    Accounts receivable, net

     

    34,855

     

     

     

    21,547

     

    Inventory

     

    16,276

     

     

     

    10,344

     

    Current portion of contract assets

     

    696

     

     

     

    1,397

     

    Current portion of commission asset

     

    5,256

     

     

     

    4,387

     

    Prepaid expenses and other current assets

     

    21,050

     

     

     

    16,957

     

    Total current assets

     

    134,401

     

     

     

    173,358

     

    Contract assets, noncurrent

     

    672

     

     

     

    964

     

    Commission asset, noncurrent

     

    7,385

     

     

     

    7,249

     

    Property and equipment, net

     

    120,842

     

     

     

    113,161

     

    Operating lease right-of-use assets

     

    14,297

     

     

     

    1,195

     

    Other assets

     

    869

     

     

     

    1,202

     

    Total assets

    $

    278,466

     

     

    $

    297,129

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    8,619

     

     

    $

    17,400

     

    Accrued expenses and other current liabilities

     

    17,016

     

     

     

    15,703

     

    Current portion of deferred revenue

     

    61,649

     

     

     

    46,808

     

    Current portion of operating lease liabilities

     

    2,191

     

     

     

    1,391

     

    Total current liabilities

     

    89,475

     

     

     

    81,302

     

    Deferred revenue, noncurrent

     

    23,867

     

     

     

    25,149

     

    Operating lease liabilities, noncurrent

     

    12,372

     

     

     

    —

     

    Contingent earn-out liability

     

    14,027

     

     

     

    29,119

     

    Contingently issuable common stock liability

     

    4,312

     

     

     

    6,530

     

    Public warrant liability

     

    5,428

     

     

     

    10,889

     

    Total liabilities

     

    149,481

     

     

     

    152,989

     

     

     

     

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.0001 par value; 100,000,000 authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value; 1,100,000,000 shares authorized at September 30, 2024 and December 31, 2023; 158,288,746 and 151,310,080 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively

     

    16

     

     

     

    15

     

    Additional paid-in capital

     

    468,041

     

     

     

    444,825

     

    Accumulated other comprehensive loss

     

    (128

    )

     

     

    (53

    )

    Accumulated deficit

     

    (338,944

    )

     

     

    (300,647

    )

    Stockholders' equity

     

    128,985

     

     

     

    144,140

     

    Total liabilities and stockholders' equity

    $

    278,466

     

     

    $

    297,129

     

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

    Nine Months Ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (38,297

    )

     

    $

    (90,850

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

    Depreciation and amortization

     

    11,933

     

     

     

    6,570

     

    Write-off of inventory and change in inventory reserve

     

    3,151

     

     

     

    278

     

    Loss from impairment of property and equipment

     

    209

     

     

     

    322

     

    Stock-based compensation

     

    21,364

     

     

     

    17,771

     

    Non-cash interest expense

     

    —

     

     

     

    22

     

    Amortization (accretion) of premium (discount) on marketable securities, net of change in accrued interest

     

    261

     

     

     

    (482

    )

    Non-cash lease expense

     

    1,116

     

     

     

    136

     

    Change in allowance for expected credit losses

     

    371

     

     

     

    237

     

    Loss on extinguishment of debt

     

    —

     

     

     

    626

     

    Change in fair value of earn-out liability

     

    (15,092

    )

     

     

    17,353

     

    Change in fair value of contingently issuable common stock

     

    (2,218

    )

     

     

    3,560

     

    Change in fair value of public warrant liability

     

    (5,461

    )

     

     

    5,345

     

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    (13,679

    )

     

     

    (929

    )

    Inventory

     

    (8,327

    )

     

     

    4,170

     

    Commission assets

     

    (1,005

    )

     

     

    (2,102

    )

    Contract assets

     

    993

     

     

     

    (85

    )

    Other assets

     

    333

     

     

     

    352

     

    Prepaid expenses and other current assets

     

    (4,093

    )

     

     

    (1,973

    )

    Accounts payable

     

    216

     

     

     

    (6,396

    )

    Deferred revenue

     

    13,559

     

     

     

    39,357

     

    Accrued expenses and other current liabilities

     

    1,655

     

     

     

    278

     

    Operating lease liability

     

    (1,046

    )

     

     

    (218

    )

    Net cash used in operating activities

     

    (34,057

    )

     

     

    (6,658

    )

    Cash flows from investing activities:

     

     

     

    Development of internal-use software

     

    (4,773

    )

     

     

    (2,202

    )

    Purchases of property and equipment

     

    (24,443

    )

     

     

    (51,646

    )

    Proceeds from sale of property and equipment

     

    —

     

     

     

    60

     

    Purchases of marketable securities

     

    (14,567

    )

     

     

    (58,652

    )

    Proceeds from maturities of marketable securities

     

    55,635

     

     

     

    19,647

     

    Net cash provided by (used in) investing activities

     

    11,852

     

     

     

    (92,793

    )

    Cash flows from financing activities:

     

     

     

    Proceeds from exercise of stock options

     

    1,151

     

     

     

    616

     

    Proceeds from long-term debt

     

    —

     

     

     

    1,876

     

    Repayment of principal on long-term debt

     

    —

     

     

     

    (31,876

    )

    Payment of debt issuance costs and prepayment penalty

     

    —

     

     

     

    (332

    )

    Net cash provided by (used in) financing activities

     

    1,151

     

     

     

    (29,716

    )

    Effect of exchange rate changes on cash and cash equivalents

     

    (75

    )

     

     

    1

     

    Net decrease in cash, cash equivalents and restricted cash

     

    (21,129

    )

     

     

    (129,166

    )

    Cash, cash equivalents and restricted cash

     

     

     

    Cash, cash equivalents and restricted cash at beginning of period

     

    67,437

     

     

     

    230,058

     

    Cash, cash equivalents and restricted cash at end of period

    $

    46,308

     

     

    $

    100,892

     

     

    EVOLV TECHNOLOGY

    SUMMARY OF KEY OPERATING STATISTICS

    (Unaudited)

     

     

    Three Months Ended or as of,

    ($ in thousands)

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

    New customers

     

    53

     

     

    84

     

     

    52

     

     

    60

    Annual recurring revenue

    $

    79,192

     

    $

    87,011

     

    $

    93,676

     

    $

    99,351

    Recurring revenue

    $

    18,961

     

    $

    21,016

     

    $

    23,764

     

    $

    23,678

    Total net units shipped*

     

    375

     

     

    447

     

     

    468

     

     

    458

     

    *Net Units Shipped reflects total units shipped (excluding rental units, upgrade units, etc.) less units churned.

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended,

     

     

    March 31,

    2023

     

    June 30,

    2023

     

    September 30,

    2023

     

    December 31,

    2023

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

     

     

     

    Operating expenses, GAAP

     

    $

    27,098

     

     

    $

    31,007

     

     

    $

    32,083

     

     

    $

    31,775

     

     

    $

    34,061

     

     

    $

    36,954

     

     

    $

    34,961

     

     

    $

    35,619

     

    Stock-based compensation

     

     

    (4,888

    )

     

     

    (6,518

    )

     

     

    (5,922

    )

     

     

    (6,218

    )

     

     

    (6,292

    )

     

     

    (7,254

    )

     

     

    (7,263

    )

     

     

    (3,159

    )

    Loss on impairment of lease equipment

     

     

    (137

    )

     

     

    (157

    )

     

     

    (28

    )

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (209

    )

     

     

    (15

    )

    One-time employee separation costs

     

     

    —

     

     

     

    (282

    )

     

     

    (61

    )

     

     

    (262

    )

     

     

    —

     

     

     

    (826

    )

     

     

    —

     

     

     

    (2,059

    )

    Other one-time legal and regulatory costs

     

     

    (53

    )

     

     

    (401

    )

     

     

    (884

    )

     

     

    (273

    )

     

     

    (476

    )

     

     

    (2,185

    )

     

     

    (2,339

    )

     

     

    (7,285

    )

    Adjusted operating expenses

     

    $

    22,020

     

     

    $

    23,649

     

     

    $

    25,188

     

     

    $

    25,022

     

     

    $

    27,293

     

     

    $

    26,689

     

     

    $

    25,150

     

     

    $

    23,101

     

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP OPERATING INCOME (LOSS) TO ADJUSTED OPERATING INCOME (LOSS)

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Revenue

    $

    29,100

     

     

    $

    20,580

     

     

    $

    103,865

     

     

    $

    79,565

     

    Cost of revenue

     

    12,359

     

     

     

    11,019

     

     

     

    44,577

     

     

     

    47,658

     

    Gross profit, GAAP

     

    16,741

     

     

     

    9,561

     

     

     

    59,288

     

     

     

    31,907

     

    Stock-based compensation

     

    233

     

     

     

    140

     

     

     

    788

     

     

     

    583

     

    Amortization of capitalized stock-based compensation

     

    85

     

     

     

    14

     

     

     

    137

     

     

     

    47

     

    Loss from impairment of intangible asset

     

    983

     

     

     

    —

     

     

     

    983

     

     

     

    —

     

    One-time employee separation costs

     

    —

     

     

     

    —

     

     

     

    174

     

     

     

    —

     

    One-time inventory charges

     

    123

     

     

     

    1,925

     

     

     

    2,729

     

     

     

    1,925

     

    Adjusted gross profit

    $

    18,165

     

     

    $

    11,640

     

     

    $

    64,100

     

     

    $

    34,462

     

     

     

     

     

     

     

     

     

    Gross margin %

     

    57.5

    %

     

     

    46.5

    %

     

     

    57.1

    %

     

     

    40.1

    %

    Adjusted gross margin %

     

    62.4

    %

     

     

    56.6

    %

     

     

    61.7

    %

     

     

    43.3

    %

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Revenue

    $

    27,360

     

     

    $

    19,961

     

     

    $

    74,765

     

     

    $

    58,985

     

    Cost of revenue

     

    11,551

     

     

     

    9,070

     

     

     

    32,218

     

     

     

    36,639

     

    Gross profit, GAAP

     

    15,809

     

     

     

    10,891

     

     

     

    42,547

     

     

     

    22,346

     

    Stock-based compensation

     

    244

     

     

     

    114

     

     

     

    555

     

     

     

    443

     

    Amortization of capitalized stock-based compensation

     

    23

     

     

     

    12

     

     

     

    52

     

     

     

    33

     

    One-time employee separation costs

     

    —

     

     

     

    —

     

     

     

    174

     

     

     

    —

     

    One-time inventory charges

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

     

     

    —

     

    Adjusted gross profit

    $

    17,547

     

     

    $

    11,017

     

     

    $

    45,935

     

     

    $

    22,822

     

     

     

     

     

     

     

     

     

    Gross margin %

     

    57.8

    %

     

     

    54.6

    %

     

     

    56.9

    %

     

     

    37.9

    %

    Adjusted gross margin %

     

    64.1

    %

     

     

    55.2

    %

     

     

    61.4

    %

     

     

    38.7

    %

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Operating loss, GAAP

    $

    (18,878

    )

     

    $

    (22,214

    )

     

    $

    (82,307

    )

     

    $

    (90,056

    )

    Stock-based compensation

     

    3,392

     

     

     

    6,358

     

     

     

    24,756

     

     

     

    24,129

     

    Amortization of capitalized stock-based compensation

     

    85

     

     

     

    14

     

     

     

    137

     

     

     

    47

     

    Loss on impairment of lease equipment

     

    15

     

     

     

    —

     

     

     

    224

     

     

     

    322

     

    Loss from impairment of intangible asset

     

    983

     

     

     

    —

     

     

     

    983

     

     

     

    —

     

    One-time employee separation costs

     

    2,060

     

     

     

    262

     

     

     

    3,060

     

     

     

    605

     

    One-time inventory charges

     

    123

     

     

     

    1,925

     

     

     

    2,729

     

     

     

    1,925

     

    Other one-time legal and regulatory costs

     

    7,284

     

     

     

    273

     

     

     

    12,285

     

     

     

    1,611

     

    Adjusted operating loss

    $

    (4,936

    )

     

    $

    (13,382

    )

     

    $

    (38,133

    )

     

    $

    (61,417

    )

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Operating loss, GAAP

    $

    (19,152

    )

     

    $

    (21,192

    )

     

    $

    (63,429

    )

     

    $

    (67,842

    )

    Stock-based compensation

     

    7,507

     

     

     

    6,036

     

     

     

    21,364

     

     

     

    17,771

     

    Amortization of capitalized stock-based compensation

     

    23

     

     

     

    12

     

     

     

    52

     

     

     

    33

     

    Loss on impairment of lease equipment

     

    209

     

     

     

    28

     

     

     

    209

     

     

     

    322

     

    One-time employee separation costs

     

    —

     

     

     

    61

     

     

     

    1,000

     

     

     

    343

     

    One-time inventory charges

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

     

     

    —

     

    Other one-time legal and regulatory costs

     

    2,339

     

     

     

    884

     

     

     

    5,000

     

     

     

    1,338

     

    Adjusted operating loss

    $

    (7,603

    )

     

    $

    (14,171

    )

     

    $

    (33,197

    )

     

    $

    (48,035

    )

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Net loss

    $

    (15,720

    )

     

    $

    (17,198

    )

     

    $

    (54,017

    )

     

    $

    (108,048

    )

    Depreciation & amortization

     

    5,442

     

     

     

    3,132

     

     

     

    17,375

     

     

     

    9,702

     

    Stock-based compensation

     

    3,392

     

     

     

    6,358

     

     

     

    24,756

     

     

     

    24,129

     

    Interest expense (income)

     

    (548

    )

     

     

    (1,630

    )

     

     

    (2,942

    )

     

     

    (5,573

    )

    Provision for income taxes

     

    —

     

     

     

    51

     

     

     

    —

     

     

     

    51

     

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    626

     

    Change in fair value of contingent earn-out liability

     

    (1,218

    )

     

     

    (2,452

    )

     

     

    (16,310

    )

     

     

    14,901

     

    Change in fair value of contingently issuable common stock liability

     

    (311

    )

     

     

    (422

    )

     

     

    (2,529

    )

     

     

    3,138

     

    Change in fair value of public warrant liability

     

    (1,131

    )

     

     

    (580

    )

     

     

    (6,592

    )

     

     

    4,765

     

    Loss on impairment of lease equipment

     

    15

     

     

     

    —

     

     

     

    224

     

     

     

    322

     

    Loss from impairment of intangible asset

     

    983

     

     

     

    —

     

     

     

    983

     

     

     

    —

     

    One-time employee separation costs

     

    2,060

     

     

     

    262

     

     

     

    3,060

     

     

     

    605

     

    One-time inventory charges

     

    123

     

     

     

    1,925

     

     

     

    2,729

     

     

     

    1,925

     

    Other one-time legal and regulatory costs

     

    7,284

     

     

     

    273

     

     

     

    12,285

     

     

     

    1,611

     

    Adjusted EBITDA

    $

    371

     

     

    $

    (10,281

    )

     

    $

    (20,978

    )

     

    $

    (51,846

    )

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Net (loss) income

    $

    (30,443

    )

     

    $

    5,046

     

     

    $

    (38,297

    )

     

    $

    (90,850

    )

    Depreciation & amortization

     

    4,575

     

     

     

    2,620

     

     

     

    11,933

     

     

     

    6,570

     

    Stock-based compensation

     

    7,507

     

     

     

    6,036

     

     

     

    21,364

     

     

     

    17,771

     

    Interest expense (income)

     

    (628

    )

     

     

    (1,791

    )

     

     

    (2,394

    )

     

     

    (3,943

    )

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    626

     

    Change in fair value of contingent earn-out liability

     

    8,321

     

     

     

    (14,078

    )

     

     

    (15,092

    )

     

     

    17,353

     

    Change in fair value of contingently issuable common stock liability

     

    2,056

     

     

     

    (2,277

    )

     

     

    (2,218

    )

     

     

    3,560

     

    Change in fair value of public warrant liability

     

    1,576

     

     

     

    (8,156

    )

     

     

    (5,461

    )

     

     

    5,345

     

    Loss on impairment of lease equipment

     

    209

     

     

     

    28

     

     

     

    209

     

     

     

    322

     

    One-time employee separation costs

     

    —

     

     

     

    61

     

     

     

    1,000

     

     

     

    343

     

    One-time inventory charges

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

     

     

    —

     

    Other one-time legal and regulatory costs

     

    2,339

     

     

     

    884

     

     

     

    5,000

     

     

     

    1,338

     

    Adjusted EBITDA

    $

    (3,017

    )

     

    $

    (11,627

    )

     

    $

    (21,349

    )

     

    $

    (41,565

    )

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Net loss

    $

    (15,720

    )

     

    $

    (17,198

    )

     

    $

    (54,017

    )

     

    $

    (108,048

    )

    Stock-based compensation

     

    3,392

     

     

     

    6,358

     

     

     

    24,756

     

     

     

    24,129

     

    Amortization of capitalized stock-based compensation

     

    85

     

     

     

    14

     

     

     

    137

     

     

     

    47

     

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    626

     

    Change in fair value of contingent earn-out liability

     

    (1,218

    )

     

     

    (2,452

    )

     

     

    (16,310

    )

     

     

    14,901

     

    Change in fair value of contingently issuable common stock liability

     

    (311

    )

     

     

    (422

    )

     

     

    (2,529

    )

     

     

    3,138

     

    Change in fair value of public warrant liability

     

    (1,131

    )

     

     

    (580

    )

     

     

    (6,592

    )

     

     

    4,765

     

    Loss on impairment of lease equipment

     

    15

     

     

     

    —

     

     

     

    224

     

     

     

    322

     

    Loss from impairment of intangible asset

     

    983

     

     

     

    —

     

     

     

    983

     

     

     

    —

     

    One-time employee separation costs

     

    2,060

     

     

     

    262

     

     

     

    3,060

     

     

     

    605

     

    One-time inventory charges

     

    123

     

     

     

    1,925

     

     

     

    2,729

     

     

     

    1,925

     

    Other one-time legal and regulatory costs

     

    7,284

     

     

     

    273

     

     

     

    12,285

     

     

     

    1,611

     

    Adjusted loss

    $

    (4,438

    )

     

    $

    (11,820

    )

     

    $

    (35,274

    )

     

    $

    (55,979

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – diluted

     

    158,997,410

     

     

     

    151,087,430

     

     

     

    156,573,886

     

     

     

    149,168,105

     

     

     

     

     

     

     

     

     

    Adjusted loss per share – diluted

    $

    (0.03

    )

     

    $

    (0.08

    )

     

    $

    (0.23

    )

     

    $

    (0.38

    )

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    (Restated)

     

     

     

    (Restated)

    Net (loss) income

    $

    (30,443

    )

     

    $

    5,046

     

     

    $

    (38,297

    )

     

    $

    (90,850

    )

    Stock-based compensation

     

    7,507

     

     

     

    6,036

     

     

     

    21,364

     

     

     

    17,771

     

    Amortization of capitalized stock-based compensation

     

    23

     

     

     

    12

     

     

     

    52

     

     

     

    33

     

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    626

     

    Change in fair value of contingent earn-out liability

     

    8,321

     

     

     

    (14,078

    )

     

     

    (15,092

    )

     

     

    17,353

     

    Change in fair value of contingently issuable common stock liability

     

    2,056

     

     

     

    (2,277

    )

     

     

    (2,218

    )

     

     

    3,560

     

    Change in fair value of public warrant liability

     

    1,576

     

     

     

    (8,156

    )

     

     

    (5,461

    )

     

     

    5,345

     

    Loss on impairment of lease equipment

     

    209

     

     

     

    28

     

     

     

    209

     

     

     

    322

     

    One-time employee separation costs

     

    —

     

     

     

    61

     

     

     

    1,000

     

     

     

    343

     

    One-time inventory charges

     

    1,471

     

     

     

    —

     

     

     

    2,607

     

     

     

    —

     

    Other one-time legal and regulatory costs

     

    2,339

     

     

     

    884

     

     

     

    5,000

     

     

     

    1,338

     

    Adjusted loss

    $

    (6,941

    )

     

    $

    (12,444

    )

     

    $

    (30,836

    )

     

    $

    (44,159

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – diluted

     

    157,709,229

     

     

     

    150,206,893

     

     

     

    155,760,149

     

     

     

    148,521,299

     

     

     

     

     

     

     

     

     

    Adjusted loss per share – diluted

    $

    (0.04

    )

     

    $

    (0.08

    )

     

    $

    (0.20

    )

     

    $

    (0.30

    )

    *In the consolidated statements of operations, one-time inventory reserves were recorded in cost of product revenue and one-time legal and regulatory costs were recorded in general and administrative expense. Stock-based compensation, amortization of capitalized stock-based compensation, and one-time employee termination costs were recorded as follows. Prior period amounts are being shown for comparative purposes:

     

    Three Months Ended,

     

    March 31,

    2023

     

    June 30,

    2023

     

    September 30,

    2023

     

    December 31,

    2023

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

    (Restated)

     

     

     

     

    Stock-based compensation:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of product revenue

    $

    16

     

    $

    12

     

    $

    —

     

    $

    6

     

    $

    —

     

    $

    5

     

    $

    4

     

    $

    8

     

    Cost of subscription revenue

     

    52

     

     

    82

     

     

    74

     

     

    82

     

     

    91

     

     

    110

     

     

    169

     

     

    154

     

    Cost of service revenue

     

    47

     

     

    61

     

     

    38

     

     

    47

     

     

    44

     

     

    51

     

     

    63

     

     

    61

     

    Cost of license fee and other revenue

     

    31

     

     

    28

     

     

    2

     

     

    5

     

     

    3

     

     

    7

     

     

    8

     

     

    10

     

    Research and development

     

    843

     

     

    1,232

     

     

    1,148

     

     

    1,079

     

     

    902

     

     

    1,222

     

     

    1,243

     

     

    1,153

     

    Sales and marketing

     

    1,980

     

     

    2,536

     

     

    2,293

     

     

    2,572

     

     

    2,959

     

     

    2,724

     

     

    2,516

     

     

    2,747

     

    General and administrative

     

    2,065

     

     

    2,750

     

     

    2,481

     

     

    2,567

     

     

    2,431

     

     

    3,308

     

     

    3,504

     

     

    (741

    )

    Total stock-based compensation

    $

    5,034

     

    $

    6,701

     

    $

    6,036

     

    $

    6,358

     

    $

    6,430

     

    $

    7,427

     

    $

    7,507

     

    $

    3,392

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Amortization of capitalized stock-based compensation:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of subscription revenue

     

    5

     

     

    5

     

     

    6

     

     

    8

     

     

    8

     

     

    8

     

     

    13

     

     

    47

     

    Cost of service revenue

     

    5

     

     

    6

     

     

    6

     

     

    6

     

     

    6

     

     

    7

     

     

    10

     

     

    38

     

    Total amortization of capitalized stock-based compensation

    $

    10

     

    $

    11

     

    $

    12

     

    $

    14

     

    $

    14

     

    $

    15

     

    $

    23

     

    $

    85

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    One-time employee separation costs:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of service revenue

    $

    —

     

    $

    —

     

    $

    —

     

    $

    —

     

    $

    —

     

    $

    174

     

    $

    —

     

    $

    —

     

    Sales and marketing

     

    —

     

     

    282

     

     

    61

     

     

    262

     

     

    —

     

     

    794

     

     

    —

     

     

    63

     

    General and administrative

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    32

     

     

    —

     

     

    1,997

     

    Total other one-time expenses

    $

    —

     

    $

    282

     

    $

    61

     

    $

    262

     

    $

    —

     

    $

    1,000

     

    $

    —

     

    $

    2,060

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250428860927/en/

    Investor Relations:

    Brian Norris

    Senior Vice President of Finance and Investor Relations

    [email protected]

    Get the next $EVLV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EVLV

    DatePrice TargetRatingAnalyst
    5/21/2025$7.50Market Perform → Outperform
    Northland Capital
    10/28/2024Outperform → Market Perform
    Northland Capital
    5/20/2024$8.50 → $5.75Buy
    Craig Hallum
    5/10/2024$6.00 → $3.50Buy → Hold
    Lake Street
    11/21/2023$6.00Buy
    Lake Street
    4/28/2023$6.00Buy
    Craig Hallum
    2/8/2023$5.40Overweight
    Cantor Fitzgerald
    3/15/2022$10.00 → $2.00Buy → Hold
    Stifel
    More analyst ratings

    $EVLV
    Leadership Updates

    Live Leadership Updates

    See more
    • Evolv Technology Appoints Chris Kutsor as Chief Financial Officer

      –Evolv Welcomes Proven High-Tech Public Company CFO as Company Enters New Stage of Growth– Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced the appointment of Mr. Chris Kutsor as Chief Financial Officer. The appointment will be effective one business day following the filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423812661/en/Chris Kutsor, Chief Financial Officer "We are thrilled to welcome Chris to our le

      4/23/25 8:00:00 AM ET
      $EVLV
      $MSI
      Computer peripheral equipment
      Technology
      Radio And Television Broadcasting And Communications Equipment
    • Partnership with Cosm Reinforces Evolv Technology's Sports Industry Position as Innovation Leader

      Evolv brings advanced fan-friendly screening experience to Cosm's initial sites in Los Angeles and Dallas Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it recently entered a partnership with Cosm, the immersive entertainment company pioneering news ways to experience sports and entertainment content. The partnership brings Evolv's advanced Express® systems to Cosm's first two locations, in the Los Angeles and Dallas metro areas. Express will be used to help deliver the secure, fast, and convenient entry screening process at the Cosm sites for major events that p

      4/16/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • San Francisco Giants Deploy Latest Evolv Express® Gen2 Systems for 2025 Season

      Oracle Park upgrades Evolv Express systems initially deployed in 2021 to a new fleet, becoming the first professional sports team to renew its four-year subscription Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced an extended and expanded relationship with the San Francisco Giants. Under the new agreement, which will see Evolv designated as a Proud Partner of the team, the existing fleet of 20 Evolv Express security systems will be swapped for Evolv's latest Gen2 units offering enhanced mobility and easier deployment. Evolv Express systems have been used to screen

      4/10/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    SEC Filings

    See more
    • SEC Form 10-Q filed by Evolv Technologies Holdings Inc.

      10-Q - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

      5/20/25 4:25:54 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technologies Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

      5/20/25 4:07:17 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • SEC Form NT 10-Q filed by Evolv Technologies Holdings Inc.

      NT 10-Q - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

      5/15/25 5:22:59 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Financial Officer Kutsor George C

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      5/5/25 5:00:11 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • SEC Form 3 filed by new insider Kutsor George C

      3 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      5/5/25 4:59:34 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • SEC Form 4 filed by Director Sullivan Mark J.

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      3/5/25 4:09:18 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Glat Neil bought $24,999 worth of shares (8,333 units at $3.00), increasing direct ownership by 5% to 162,355 units (SEC Form 4)

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      8/14/24 4:05:45 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Director Gonzales David Mounts bought $150,000 worth of shares (50,000 units at $3.00), increasing direct ownership by 71% to 120,544 units (SEC Form 4)

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      8/14/24 4:05:10 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Gonzales David Mounts bought $193,000 worth of shares (50,000 units at $3.86) (SEC Form 4)

      4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

      3/7/24 5:32:10 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Evolv Technology Reports First Quarter Financial Results

      — Company Surpasses 6,600 Total Subscriptions — — Company Expects Revenue Growth of 20%-25% with Positive Full Year Adjusted EBITDA in 2025 — Q1'25 Revenue of $32.0 million, up 44% year-over-year Q1'25 Ending ARR1 of $106.0 million, up 34% year-over-year Q1'25 Net Loss of $(1.7) million, compared to $(11.3) million in Q1'24 Q1'25 Net Profit Margin of (5)%, compared to (51)% in Q1'24 Q1'25 Adjusted EBITDA1 of $1.7 million, with Adjusted EBITDA Margin1 of 5% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended March 31,

      5/20/25 4:05:00 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technology Provides Business Update

      — Company Estimates Revenue Growth of 40%+ in Q1'25 — — Company Reiterates Plans to Issue Final Q1'25 Results on May 20, 2025 — Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today provided an update on its preliminary financial results for the first quarter of 2025 as well as its upcoming plans to file its related Quarterly Report on Form 10-Q with the Securities and Exchange Commission. Company Provides Preliminary Update for First Quarter of 2025 The Company today provided an update on preliminary results for the first quarter of 2025. Based on preliminary estimates which a

      5/15/25 6:10:00 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technology to Present at Cowen Technology Conference

      Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced its scheduled participation in the Cowen Technology Conference on Thursday, May 29, 2025 in New York, New York. Presenting on behalf of the Company will be Mr. John Kedzierski, the Company's President and Chief Executive Officer and Mr. Chris Kutsor, the Company's Chief Financial Officer. Additional details including a link to the associated webcast will be available at the Company's investor relations website at https://ir.evolvtechnology.com. About Evolv Technology Evolv Technology (NASDAQ:EVLV) is designed to transform

      5/8/25 4:05:00 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Financials

    Live finance-specific insights

    See more
    • Evolv Technology Reports First Quarter Financial Results

      — Company Surpasses 6,600 Total Subscriptions — — Company Expects Revenue Growth of 20%-25% with Positive Full Year Adjusted EBITDA in 2025 — Q1'25 Revenue of $32.0 million, up 44% year-over-year Q1'25 Ending ARR1 of $106.0 million, up 34% year-over-year Q1'25 Net Loss of $(1.7) million, compared to $(11.3) million in Q1'24 Q1'25 Net Profit Margin of (5)%, compared to (51)% in Q1'24 Q1'25 Adjusted EBITDA1 of $1.7 million, with Adjusted EBITDA Margin1 of 5% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended March 31,

      5/20/25 4:05:00 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technology Provides Business Update

      — Company Estimates Revenue Growth of 40%+ in Q1'25 — — Company Reiterates Plans to Issue Final Q1'25 Results on May 20, 2025 — Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today provided an update on its preliminary financial results for the first quarter of 2025 as well as its upcoming plans to file its related Quarterly Report on Form 10-Q with the Securities and Exchange Commission. Company Provides Preliminary Update for First Quarter of 2025 The Company today provided an update on preliminary results for the first quarter of 2025. Based on preliminary estimates which a

      5/15/25 6:10:00 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technology to Release First Quarter Financial Results on May 20, 2025

      Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the first quarter of 2025 on Tuesday, May 20, 2025, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv Technologies Holdings, Inc (NASDAQ:EVLV) is designed to transform human security to make a safer, f

      5/7/25 8:00:00 AM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

      SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

      12/12/24 3:21:41 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

      SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

      11/12/24 2:31:40 PM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

      SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

      11/7/24 4:31:46 PM ET
      $EVLV
      Computer peripheral equipment
      Technology

    $EVLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Evolv Technologies Holdings upgraded by Northland Capital with a new price target

      Northland Capital upgraded Evolv Technologies Holdings from Market Perform to Outperform and set a new price target of $7.50

      5/21/25 8:40:06 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Evolv Technologies Holdings downgraded by Northland Capital

      Northland Capital downgraded Evolv Technologies Holdings from Outperform to Market Perform

      10/28/24 8:56:54 AM ET
      $EVLV
      Computer peripheral equipment
      Technology
    • Craig Hallum resumed coverage on Evolv Technologies Holdings with a new price target

      Craig Hallum resumed coverage of Evolv Technologies Holdings with a rating of Buy and set a new price target of $5.75 from $8.50 previously

      5/20/24 8:37:06 AM ET
      $EVLV
      Computer peripheral equipment
      Technology